Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-10-12

Clinical Trial Update: Levofloxacin Pharmacokinetics (PK) in the Severely Obese [Phase 4]

View source ↗

Summary

Phase 4 study assessing the pharmacokinetics of levofloxacin in severely obese individuals; the trial is completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levofloxacin (Levofloxacin)

Snippet

Sponsor: Joel Thompson, PhD | Conditions: Obesity, Critical Illness | Phase 4 | Status: COMPLETED | Results posted: 2012-10-12